DK Moczulski, H Fojcik, A Wielgorecki, W Trautsolt, … - Diabetic …, 2007 - pt.wkhealth.com Methods: We studied seven male patients with Type 1 diabetes and proteinuria and 12 male
patients with Type 1 diabetes and normoalbuminuria after at least 20 years of diabetes
duration. The expression of genes was examined using the microarray method with ... Cited by 4 - Related articles - BL Direct - All 5 versions
A Solini, E Santini, S Madec, S Cuccato, E … - Growth …, 2007 - informahealthcare.com Endothelin-1 (ET-1) promotes the contractile ability of fibroblasts, essential for wound closure
and reconstitution of the dermis. Wound healing is impaired in type 2 diabetic patients (D). We
compared the effect of ET-1 on proliferative transforming growth factor (TGFβ 1 ) ... Cited by 3 - Related articles - BL Direct - All 4 versions
S Martini, F Eichinger, V Nair, M Kretzler - Reviews in Endocrine & Metabolic …, 2008 - Springer Abstract Diabetic nephropathy (DN) is the most common cause for end stage renal disease
(ESRD). Next to environmental factors, genetic predispositions determine the susceptibility for
DN and its rate of progression to ESRD. With the availability of genome wide expression ... Cited by 2 - Related articles - All 2 versions
EJ So, HJ Kim, CW Kim - Proteomics Clin. Appl, 2008 - interscience.wiley.com Hyperglycemia is a major key factor in the pathogenesis of microvascular complications of
diabetes, including diabetic nephropathy (DN). Most studies to date have focused on the glomerular
abnormalities found in DN. However, nephromegaly in the early stages of diabetes and ... Related articles